Categories AlphaGraphs, Earnings, Health Care

Earnings: Trxade Health (MEDS) reports 16% rise in FY22 revenue; loss narrows

Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a double-digit increase in revenues for fiscal 2022. The company’s full-year net loss narrowed from the prior year.

Revenues increased 16% from last year to $11.45 million. As a result, the net loss attributable to Trxade Health narrowed to $3.47 million or $0.41 per share in fiscal 2022 from $5.32 million or $0.65 per share in the twelve months ended December 2021.

“I am pleased with the growth we have experienced in our Trxade platform. We continue to achieve key milestones in our internal roadmap with a focus on innovation and development through our various complementary growth opportunities,” said Trxade’s CEO Suren Ajjarapu.

Trxade’s stock has gained about 52% since the beginning of the year. The shares closed Monday’s regular trading session sharply higher.

Prior Performance

  • Trxade Q3 2022 earnings infographic
  • Trxade Q2 2022 earnings infographic
  • Trxade Q1 2022 earnings infographic
  • Trxade Q4 2021 earnings infographic

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

AbbVie Q1 2025 adjusted earnings increase on 8% revenue growth; beat estimates

Biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) announced first-quarter 2025 financial results, reporting an increase in revenue and adjusted earnings. The company reported worldwide net revenues of $13.3 billion for the

Colgate-Palmolive (CL) Q1 2025 Earnings: Key financials and quarterly highlights

Colgate-Palmolive Company (NYSE: CL) reported its first quarter 2025 earnings results today. Net sales decreased 3.1% year-over-year to $4.9 billion. Organic sales growth was 1.4%. Net income attributable to Colgate-Palmolive Company rose

Meta Platforms (META) set to report Q1 earnings. Here’s what to expect

After integrating artificial intelligence into its products, Meta Platforms, Inc. (NASDAQ: META) is investing heavily in the metaverse project. Yet, the tech giant has maintained healthy cash flows and consistently

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top